Shanghai Cell Therapy Group Overview
- Year Founded
-
2013
- Status
-
IPO Registration
- Employees
-
1,144
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
14
Shanghai Cell Therapy Group General Information
Description
Developer of tumour immune cell therapy treatments. The company operates a cellular diagnosis center and provides immune cell research and treatment services. The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities.
Contact Information
Website
www.shcell.comCorporate Office
- Building 6, No. 1585 Yuanguo Road
- Anting Town, Jiading District
- Shanghai, 201805
- China
Corporate Office
- Building 6, No. 1585 Yuanguo Road
- Anting Town, Jiading District
- Shanghai, 201805
- China
Shanghai Cell Therapy Group Timeline
Shanghai Cell Therapy Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. IPO | 30-Apr-2024 | 00000 | Announced | Generating Revenue | ||
| 11. Secondary Transaction - Private | 13-Dec-2023 | 000.00 | 00000 | Completed | Generating Revenue | |
| 10. Later Stage VC (Series D2) | 08-Feb-2022 | 000.00 | 00000 | Completed | Generating Revenue | |
| 9. Later Stage VC (Series D1) | 23-Mar-2021 | 0000 | 00000 | 00.000 | Completed | Generating Revenue |
| 8. Secondary Transaction - Private | 26-Feb-2021 | 0000 | 00000 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series C2) | 01-Dec-2018 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC (Series C1) | 01-Oct-2018 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
| 5. Secondary Transaction - Private | 26-Jun-2018 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 4. Early Stage VC (Series B2) | 08-Nov-2017 | $9.1M | $58.4M | 00000 | Completed | Generating Revenue |
| 3. Early Stage VC (Series B1) | 18-Apr-2016 | $28.5M | $49.4M | 00000 | Completed | Generating Revenue |
Shanghai Cell Therapy Group Comparisons
Industry
Financing
Details
000000
00 000
Shanghai Cell Therapy Group Competitors (36)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gracell | Formerly VC-backed | Shanghai, China | 000 | 00000 | 000000&0 | 00000 |
| JW Therapeutics | Formerly VC-backed | Shanghai, China | 000 | 00000 | 00000000 | 00000 |
| Marengo Therapeutics | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| Immunophotonics | Venture Capital-Backed | Saint Louis, MO | 00 | 000.00 | 000000000 | 000.00 |
| Mabworks Biotech | Private Equity-Backed | Beijing, China | 000 | 00000 | 0000000 0000 | 00000 |
Shanghai Cell Therapy Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shanghai Cell Therapy Group Patents
Shanghai Cell Therapy Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022424159-A1 | Anti-mesothelin nanobody chimeric antigen receptor and use thereof | Pending | 29-Dec-2021 | 00000000000 | |
| AU-2022341440-A1 | Ionizable lipids, their preparation and application in gene delivery | Pending | 10-Sep-2021 | 000000000 | |
| EP-4400107-A1 | Ionizable liposome, preparation thereof, and application thereof in gene delivery | Pending | 10-Sep-2021 | 000000000 | |
| EP-4081545-A2 | Cell expressing immune modulatory molecules and system for expressing immune modulatory molecules | Pending | 28-Dec-2019 | 0000000000 | |
| US-20230058519-A1 | Cell expressing immune modulatory molecules and system for expressing immune modulatory molecules | Pending | 28-Dec-2019 | C12N5/0638 |
Shanghai Cell Therapy Group Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Na Ding Ph.D | President | |
| Qijun Qian MD | General Manager & Chairman & Executive Director |
Shanghai Cell Therapy Group Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Qijun Qian MD | Shanghai Cell Therapy Group | General Manager & Chairman & Executive Director | 000 0000 |
Shanghai Cell Therapy Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Shanghai Cell Therapy Group Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xiyang Investment | Venture Capital | Minority | 000 0000 | 000000 0 |
| CCB International | PE/Buyout | Minority | 000 0000 | 000000 0 |
| Jiuzhou Venture | Venture Capital | Minority | 000 0000 | 000000 0 |
| Sun Rock Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
| China Pacific Life Insurance | Asset Manager | Minority | 000 0000 | 000000 0 |
Shanghai Cell Therapy Group FAQs
-
When was Shanghai Cell Therapy Group founded?
Shanghai Cell Therapy Group was founded in 2013.
-
Where is Shanghai Cell Therapy Group headquartered?
Shanghai Cell Therapy Group is headquartered in Shanghai, China.
-
What is the size of Shanghai Cell Therapy Group?
Shanghai Cell Therapy Group has 1,144 total employees.
-
What industry is Shanghai Cell Therapy Group in?
Shanghai Cell Therapy Group’s primary industry is Biotechnology.
-
Is Shanghai Cell Therapy Group a private or public company?
Shanghai Cell Therapy Group is a Private company.
-
What is Shanghai Cell Therapy Group’s current revenue?
The current revenue for Shanghai Cell Therapy Group is 000000.
-
How much funding has Shanghai Cell Therapy Group raised over time?
Shanghai Cell Therapy Group has raised $285M.
-
Who are Shanghai Cell Therapy Group’s investors?
Xiyang Investment, CCB International, Jiuzhou Venture, Sun Rock Capital, and China Pacific Life Insurance are 5 of 14 investors who have invested in Shanghai Cell Therapy Group.
-
Who are Shanghai Cell Therapy Group’s competitors?
Gracell, JW Therapeutics, Marengo Therapeutics, Immunophotonics, and Mabworks Biotech are some of the 36 competitors of Shanghai Cell Therapy Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
